Insider Trading History of Lawrence Thomas R

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Lawrence Thomas R since 2011. The trader's CIK number is 1408568. At the time of the last reporting, Lawrence Thomas R was the Director of Cumberland Pharmaceuticals Inc. (stock ticker symbol CPIX). Also see all insider trading activities at Cumberland Pharmaceuticals Inc.


Yearly summary of insider trading at Cumberland Pharmaceuticals Inc (CPIX) by Lawrence Thomas R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 CPIX 0 $0 26,781 $168,073 0 $0
2016 CPIX 0 $0 29,600 $143,451 0 $0
2015 CPIX 0 $0 16,000 $105,420 0 $0
2014 CPIX 0 $0 45,000 $218,200 0 $0
2013 CPIX 0 $0 12,000 $59,880 0 $0
2012 CPIX 0 $0 6,222 $27,687 8,000 $28,000
2011 CPIX 0 $0 40,000 $220,200 23,466 $38,132


Insider trading of Cumberland Pharmaceuticals Inc (CPIX) by Lawrence Thomas R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-04-07 CPIX Sale 6,000 6.40 38,400
2017-03-13 CPIX Sale 20,781 6.24 129,673
2016-11-15 CPIX Sale 18,600 5.07 94,302
2016-08-17 CPIX Sale 3,000 4.60 13,799
2016-05-26 CPIX Sale 3,000 4.55 13,650
2016-03-17 CPIX Sale 5,000 4.34 21,700
2015-11-19 CPIX Sale 4,000 5.61 22,440
2015-05-26 CPIX Sale 6,000 6.88 41,280
2015-03-19 CPIX Sale 6,000 6.95 41,700
2014-11-20 CPIX Sale 10,000 5.12 51,200
2014-08-21 CPIX Sale 15,000 5.08 76,200
2014-03-19 CPIX Sale 20,000 4.54 90,800
2013-11-21 CPIX Sale 12,000 4.99 59,880
2012-11-16 CPIX Sale 6,222 4.45 27,687
2012-11-16 CPIX Option Ex 8,000 3.50 28,000
2011-11-21 CPIX Option Ex 11,733 1.62 19,066
2011-11-21 CPIX Sale 20,000 5.73 114,600
2011-03-24 CPIX Sale 20,000 5.28 105,600
2011-03-24 CPIX Option Ex 11,733 1.62 19,066

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lawrence Thomas R (Director of Cumberland Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.